June 27, 2017
Bristol-Myers Squibb and Sanofi have escaped a whistleblower False Claims Act suit accusing them of prompting Medicaid overbilling through deceptive marketing of the blood thinner Plavix, after a New Jersey federal judge ruled Tuesday that automatic payment requirements made any implied certifications regarding the drug's effectiveness immaterial to payment.
June 29, 2016
A New Jersey federal judge on Wednesday reopened a False Claims Act suit against Sanofi-Aventis US LLC and Bristol-Myers Squibb Co. following the U.S. Supreme Court's recent Escobar ruling that liability under the statute can be triggered by failure to comply with regulations that aren't explicit conditions of payment.
December 16, 2015
A New Jersey federal judge on Wednesday paused a False Claims Act accusing Sanofi-Aventis US LLC and Bristol-Myers Squibb Co. of deceptively pushing the blood thinner Plavix, pending a U.S. Supreme Court decision in a case over the so-called implied certification theory.
August 20, 2015
A New Jersey judge on Thursday stripped Medicare and Medicaid claims involving 33 states from the False Claims Act suit of a former Sanofi-Aventis US LLC sales representative accusing the drugmaker and Bristol-Myers Squibb Co. of deceptively pushing the blood thinner Plavix.